“There were no significant adverse findings noted in a 6-month toxicology study in rats administered dose levels ranging from 7.5x108 – 7.5x109 vg/animal.”
✓ VerifiedFDA summary basis for approval, p. 11Source ↗
Pivotal GLP studies
Rat single-dose intraputaminal 30-day and 6-month GLP tox/BD; NHP 30-day poloxamer study; NHP 4-week route BD study
“Two single-dose studies were conducted to assess toxicity at 30-days and 6 months.”
Bilateral intraputaminal infusion (also substantia nigra in rat; ICV/IT in NHP BD study)
“In the 6-month study a single eladocagene exuparvovec administration via bilateral IPI at doses up to 7.5×109 vg was generally well tolerated with no obvious signs of toxicity.”